Abstract Chromogranins A, B, and C, proteins that are co-stored and co-released with peptides and amines, have been identified in a variety of neuroendocrine tissues, both normal and neoplastic. We examined the secretion of chromogranin A and chromogranin A + B by hormone-producing tumours in patients with endocrine pancreatic tumours, carcinoid tumours, pheochromocytomas, and small cell lung cancer. The radioimmunoassay determining the plasma concentrations of chromogranin A + B showed a greater sensitivity than that determining chromogranin A alone. All patients with endocrine pancreatic tumours, carcinoids, and pheochromocytomas had increased levels of chromograin A + B, whereas a small number of the patients ( The acidic soluble proteins of chromaffin granules have been collectively named chromogranins (1) . These chromogranins consist of three families, chromogranin A, B and C.
Chromogranin A was first isolated from catecholamine storage vesicles in the adrenal medulla (1) and was later characterized by Schneider et al. (2) . (3) (4) (5) (6) . It has also been found in sympathetic neurons (7-9), brain (10) and lymphoid tissue (11) . A second family of proteins, which has been named chromogranin B or secretogranin I, has re¬ cently been identified (12, 13) . It has been shown to be the predominant component in rat and human chromaffin granules (12, 14, 15) , whereas chromo¬ granin A is the major form in bovine chromaffin granules. Chromogranin B/secretogranin I also has a wide-spread distribution in endocrine and neu¬ ronal tissues (15) (16) (17) . Chromogranin C, the third family of these proteins, was first isolated from the pituitary gland by Rosa & Zanini (18) . It has also been found in other endocrine organs (15, 17, 19 (Fig. 1) . The elution rate was 12 ml/h. All fractions were tested by immunoneutralization (100 ug/l diluted antiserum). The fractions (denoted F, and F4 in Fig. 1 
Radioimmunoassay
The chromogranin A radioimmunoassay performed by O'Connor and co-workers has previously been described (20, 21) .
The chromogranin fraction selected from our prepa¬ ration was labelled with 12T using the chloramine-T method, by incubating 3 ug of protein with 5 \ig chlora¬ mine-T and 0. When the plasma concentrations of chromogranin A + B were determined in a RIA using our own antiserum in 22 normal controls selected among persons from routine health check-ups (11 men, 11 women, mean age 45 years), the median concen¬ tration was 160 ug/l, range 102-322 (Fig. 4, range 697-12510 ug/l (Fig. 4 and Table 1 ). The patients with insulinomas and gastrinomas had the highest levels. Patients with non-functioning tu¬ mours also had clearly elevated values with a median of 1034, range 761-2232 ug/l. Somewhat lower, but still clearly elevated levels were found in patients with the WDHA syndrome.
All carcinoid patients (100%) showed increased levels, with a median plasma concentration of 5055, range 1090-19054 ug/l (Fig. 4 and Table 1 ). The patients with mid-gut and fore-gut carcinoid tu¬ mours had median values in the same order (5529 Ug/l and 4725 ug/l, respectively). The highest value in the whole series was found in a patient with a mid-gut carcinoid tumour (19054 ug/l).
In the patients with tumours of medullary ad¬ renal origin, the plasma concentration of chromo¬ granin A + B was increased in all three. (Fig. 4 and Table 1 ). The highest level, 3784 ug/l was observed in the ganglioneuroblastoma patient.
Among the 15 (Fig. 5a) strated the presence of these proteins in neuroen¬ docrine tissues in the body (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . O'Connor and colleagues found elevated levels of chromogranin A in patients with peptide-producing tumours (21 (25) . The neuroendocrine characteristics of some of these tumours are well known, but it is also known that such neuroendocrine characteris¬ tics vary from one tumour to another (26) (28) .
Several studies of the amino acid sequences of chromogranin A have shown the presence of basic pairs which are potential cleavage sites for the gen¬ eration of smaller polypeptides (29) . A role of chro¬ mogranin A and B as precursors for other peptides has been suggested, since a homology has been found between chromogranin A and pancreastatin (30) , a newly characterized smaller peptide (31) .
Chromogranin B has been shown to be the major component of human chromograffin granules (12) (13) (14) . Thus 
